TCRT
Alaunos Therapeutics, Inc. - Common Stock (TCRT)
$84
About Alaunos Therapeutics, Inc. - Common Stock (TCRT)
Alaunos Therapeutics, Inc. is a biopharmaceutical company and clinical-stage oncology-focused cell therapy company, which engages in the development of adoptive TCR engineered T-cell therapies, or TCR-T, designed to treat multiple solid tumor types in large cancer patient populations with unmet clinical needs. Its pipeline includes Library TCR-T cell and mblL-15 TCR-T cell Therapy. The company was founded in 2003 and is headquartered in Fort Lauderdale, FL.
Details
Daily high
$1.84
Daily low
$1.73
Price at open
$1.76
52 Week High
$4.50
52 Week Low
$0.72
Market cap
6.5M
Dividend yield
-
Volume
114,888
Avg. volume
21.6M
P/E ratio
-.92
Alaunos Therapeutics, Inc. - Common Stock News
Details
Daily high
$1.84
Daily low
$1.73
Price at open
$1.76
52 Week High
$4.50
52 Week Low
$0.72
Market cap
6.5M
Dividend yield
-
Volume
114,888
Avg. volume
21.6M
P/E ratio
-.92